ATP1A1 and cancer: In addition, pan-cancer drug sensitivity analyses were conducted using pharmacogenomic datasets.<h4>Results</h4>ATP1A1 was identified as the only LASSO-selected gene demonstrating consistent prognostic significance, with higher expression associated with improved survival outcomes.